Gilead Sciences (GILD)

Company Ticker Sector | Industry Quality PAR
Gilead Sciences GILD Healthcare | Drug Manufacturers - General 58 6.4%
Current Price (07/27) $68.93
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 25,564.0
Sales Growth Forecast 1.2%
Net Profit Margin 29.9%
Projected Shares Outstanding 1,220.30
EPS - Five year Forecast $6.64
Average P/E Ratio 12.0
Projected Average Price $79.66
Price Appreciation (Annualized) 2.9%
Annual Dividend Yield 3.5%
Projected Annual Return 6.4%
Quality
Financial Strength 89 22.2
EPS Stability 43 10.8
Industry Sales Growth Rate 8.0% 1.8
Industry Net Profit Margin 22.5% 16.6
Calculated Quality Rating 51.5
Fool CAPS

Total Players

3362 Outperforms
89 Underperforms
 

All-Stars (635)

624 Outperforms (98%)
11 Underperforms
 
Fundamental Data Updated: 07/02/2021

MIPAR 7.1%  
Sweet Spot 12.1% - 17.1%  

Top In Drug Manufacturers - General

Ticker Quality PAR
BIIB 94 8.9%
MRK 89 9.5%
AMGN 94 5.8%
JNJ 90 6.1%
LLY 91 4.7%

Top In Healthcare

Ticker Quality PAR
ADUS 94 17.7%
ENSG 93 14.2%
JAZZ 77 15.8%
LMAT 81 12.4%
BIIB 94 8.9%